A General Immune Boost Instead of a Specific Target

Most cancer immunotherapies rely on identifying and attacking neoepitopes—proteins that arise from mutations specific to a patient’s tumor. This approach works best in cancers with high mutation loads, such as melanoma, but has limited success in tumors with low mutational burden. A study published in Nature Biomedical Engineering and conducted by scientists at the University of Florida challenges that model.

In their experiments, researchers used an experimental mRNA vaccine delivered via lipid nanoparticles, similar to the technology used in COVID-19 vaccines. But instead of encoding a viral protein, this vaccine instructs the immune system to produce proteins that activate an immune response.

One of these proteins, PD-L1, is commonly found on cancer cells and helps them evade immune detection. By artificially inducing PD-L1 expression in tumors, the vaccine made the cancer cells more visible to the immune system, improving the effects of immune checkpoint inhibitors.

Making Resistant Tumors Respond to Treatment

In mouse models of melanoma, the mRNA vaccine cleared drug-resistant tumors and triggered “antigenic spreading”—a process where the immune system begins to recognize and attack multiple tumor-related antigens. In some cases, the vaccine worked even without additional treatments. It was also tested in models of brain, skin, and bone cancers with similarly promising results.

Researchers demonstrated that tumors resistant to checkpoint inhibitors lacked these early immune signals, but became sensitive when treated with RNA-loaded lipid particles that boosted interferon activity. This led to a broader immune reaction, enabling previously unresponsive tumors to respond to immunotherapy.

Together, these results highlight a new paradigm in cancer treatment: instead of customizing a vaccine to match each patient’s unique tumor profile, it may be possible to create a general-purpose vaccine that teaches the immune system to react aggressively to cancer, regardless of the tumor’s specifics.

Laying the Groundwork for an Off-the-Shelf Cancer Vaccine

Dr. Elias Sayour, a pediatric oncologist at the University of Florida and lead investigator on the study, described the results as “a proof of concept” that such a vaccine could eventually become an off-the-shelf solution. Co-author Dr. Duane Mitchell added that this approach may pave the way for more accessible and broadly applicable cancer treatments.

While these findings are based on animal studies, they offer a strong foundation for clinical research. If the vaccine proves effective in humans, it could significantly improve cancer immunotherapy, especially for patients with tumors that previously showed little to no response.

The research not only expands the potential use of mRNA technology beyond infectious disease but also underscores the power of immune system priming. As development continues, a universal cancer vaccine may soon become a powerful tool in the fight against one of the world’s most complex diseases.

[Source]

The post Universal Cancer Vaccine Shows Promise in Boosting Immunotherapy Response appeared first on Medical Journal Daily.

The study, published in the British Journal of Sports Medicine, evaluated high-quality meta-analyses of randomized controlled trials. The evidence strongly supports the integration of exercise into cancer treatment protocols, particularly when compared to usual care or no exercise at all.

Exercise Reduces Key Side Effects of Cancer Treatment

The review highlights that exercise helps counteract several serious side effects commonly experienced during cancer treatment. One of the most notable benefits is the reduction in cardiotoxicity—heart damage often caused by chemotherapy—which was significantly less in patients who engaged in physical activity.

Exercise also proved effective in managing chemotherapy-induced peripheral neuropathy (CIPN), a condition that leads to nerve damage and affects balance and coordination. Cognitive impairment, often described as “brain fog,” improved in patients who exercised regularly, with many reporting better mental clarity and reduced fatigue. Additionally, dyspnoea, or shortness of breath, frequently seen in lung and advanced-stage cancers, was also alleviated through consistent physical activity.

Beyond physical health, exercise was found to positively impact several quality-of-life indicators. These included improved sleep quality, reduced stress and anxiety, and enhanced social interaction. This is particularly relevant as many cancer patients struggle with isolation and emotional fatigue during treatment.

Importantly, the review showed moderate- to high-certainty evidence that preoperative exercise reduced post-surgery complications, length of hospital stay, and even mortality.

In addition to subjective outcomes, researchers noted changes in biological markers. Levels of insulin, insulin-like growth factor 1 (IGF-1), and C-reactive protein (CRP)—all key indicators of inflammation and metabolic health—were positively influenced by exercise. Body composition also improved, with patients experiencing healthier muscle-to-fat ratios.

Various Forms of Exercise Prove Effective

The review included a range of physical activities: aerobic training, resistance exercise, high-intensity interval training (HIIT), tai chi, and yoga. All were associated with measurable benefits. This suggests patients can choose the type of exercise that best suits their health status and personal preferences.

Mind-body practices like yoga and tai chi not only improved physical symptoms but also supported emotional and mental health. This flexibility in approach makes it easier for clinicians to recommend activity plans tailored to individual patients.

Given the moderate- to high-certainty of the findings, the study’s authors advocate for exercise to become a standard component of cancer treatment. Currently, many cancer patients receive limited or no guidance on physical activity during their care journey.

Implications for Cancer Care Protocols

While the study underscores the value of exercise, experts also emphasize the need for personalized programs. As Celene Doherty from Cancer Research UK noted, patients should engage in exercise at their own pace and consult with their care teams for appropriate guidance.

This umbrella review provides strong, evidence-based support for including structured exercise in cancer care. From reducing cardiotoxicity and nerve damage to enhancing sleep and emotional well-being, the health benefits are wide-ranging.

The findings encourage oncologists to consider integrating physical activity into standard treatment plans, offering patients not just extended survival but improved day-to-day quality of life.

[Source]

The post Exercise Significantly Reduces Cancer Treatment Side Effects Major Review Finds appeared first on Medical Journal Daily.